Vineet Laborator

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE505Y01010
  • NSEID: VINEETLAB
  • BSEID: 543298
INR
40.14
1.74 (4.53%)
BSENSE

Nov 20

BSE+NSE Vol: 1.48 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Vineet Laborator
Source Natural
Samrat Pharma
Sunil Healthcare
Denis Chem Lab
Phaarmasia
Amwill Health
Shelter Pharma
Zenith Drugs
Vilin Bio Med
Onyx Biotec
Why is Vineet Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a 3.12% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.58 times
  • The company has been able to generate a Return on Equity (avg) of 5.42% signifying low profitability per unit of shareholders funds
2
Positive results in Sep 26
  • PAT(Latest six months) Higher at Rs 1.63 cr
  • ROCE(HY) Highest at 7.40%
  • PBT LESS OI(Q) Highest at Rs 1.37 cr.
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 19-Nov-26 and has generated 2.4% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
4
With ROCE of 8.1, it has a Very Attractive valuation with a 1.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 13.45%, its profits have risen by 119.2% ; the PEG ratio of the company is 0.2
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Vineet Laborator should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vineet Laborator for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Vineet Laborator
13.45%
0.27
50.74%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-24.54%
EBIT Growth (5y)
3.12%
EBIT to Interest (avg)
0.77
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
1.42
Tax Ratio
19.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
-6.11%
ROE (avg)
5.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
24
Industry P/E
40
Price to Book Value
1.63
EV to EBIT
16.45
EV to EBITDA
12.36
EV to Capital Employed
1.34
EV to Sales
2.00
PEG Ratio
0.22
Dividend Yield
NA
ROCE (Latest)
8.15%
ROE (Latest)
6.80%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
PAT(Latest six months)

Higher at Rs 1.63 cr

ROCE(HY)

Highest at 7.40%

PBT LESS OI(Q)

Highest at Rs 1.37 cr.

-8What is not working for the Company
PAT(Q)

At Rs 0.12 cr has Fallen at -86.2% (vs previous 4Q average

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.79 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.00 times

NET SALES(Q)

At Rs 14.18 cr has Fallen at -9.0% (vs previous 4Q average

EPS(Q)

Lowest at Rs 0.06

Loading Valuation Snapshot...
Here's what is working for Vineet Laborator
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.37 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Vineet Laborator
Profit After Tax (PAT) - Quarterly
At Rs 0.12 cr has Fallen at -86.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.87 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Inventory Turnover Ratio- Half Yearly
Lowest at 0.79 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales - Quarterly
At Rs 14.18 cr has Fallen at -9.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 15.59 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.06
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Lowest at 4.00 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio